Compare Davita Inc (DVA) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Orion Office REIT Inc — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while Orion Office REIT Inc trades at $2.78 (market cap $156.87M). The key difference: Davita Inc is far larger — about 74.7× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.91% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | ONL | |
|---|---|---|
Market Cap | $11.72B | $156.87M |
Sector | Health | Real Estate |
52-Week High | $240.96 | $3.04 |
52-Week Low | $103.87 | $1.93 |
Enterprise Value | $24.44B | $573.80M |
Dividend Yield | — | 2.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
ONL trades at $2.82, up 8.46% today, with strong technical indicators showing bullish momentum. The stock shows mixed fundamentals with a low P/B ratio of 0.25 but negative profitability metrics including -65.66% net income margin. Recent Q2 2026 earnings beat expectations with EPS of $0.42 versus -$0.07 forecast, while the company continues strategic portfolio repositioning and maintains a $0.02 dividend payment.
Outlook remains cautious due to persistent net losses and declining revenue trends, though analyst consensus is evenly split between Buy and Hold ratings. Key risks include high debt levels with 39.68% debt-to-asset ratio and ongoing negative cash flow from operations. The technical bullish signal suggests short-term upside potential despite fundamental challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
